91 related articles for article (PubMed ID: 21412121)
1. Molecular angiogenesis profile as a tool to discriminate chronic pancreatitis (CP) from pancreatic cancer (PC).
Berindan-Neagoe I; Burz C; Balacescu O; Balacescu L; Seicean A; Cristea V; Irimie A
Pancreas; 2011 Apr; 40(3):482-3. PubMed ID: 21412121
[No Abstract] [Full Text] [Related]
2. Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis.
Chang MC; Chang YT; Su TC; Yang WS; Chen CL; Tien YW; Liang PC; Wei SC; Wong JM
Pancreas; 2007 Jul; 35(1):16-21. PubMed ID: 17575540
[TBL] [Abstract][Full Text] [Related]
3. Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer.
Novotný I; Dítĕ P; Dastych M; Záková A; Trna J; Novotná H; Nechutová H
Hepatogastroenterology; 2008; 55(85):1475-7. PubMed ID: 18795715
[TBL] [Abstract][Full Text] [Related]
4. Serum heat shock protein 27 is increased in chronic pancreatitis and pancreatic carcinoma.
Liao WC; Wu MS; Wang HP; Tien YW; Lin JT
Pancreas; 2009 May; 38(4):422-6. PubMed ID: 19214136
[TBL] [Abstract][Full Text] [Related]
5. Neopterin--a potential factor for differentiation between pancreatic cancer and chronic pancreatitis.
Piecuch J; Rudzki M; Orkisz W; Swietochowska E; Wielkoszyński T; Waniczek D; Arendt J; Sosada K; Zurawiński W; Ładny JR
Hepatogastroenterology; 2008; 55(81):258-61. PubMed ID: 18507120
[TBL] [Abstract][Full Text] [Related]
6. Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis.
Liggett T; Melnikov A; Yi QL; Replogle C; Brand R; Kaul K; Talamonti M; Abrams RA; Levenson V
Cancer; 2010 Apr; 116(7):1674-80. PubMed ID: 20143430
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of plasma vascular endothelial growth factor in the diagnosis of pancreatic carcinoma: differential diagnosis, tumor progression, and patient survival.
Kobayashi A; Yamaguchi T; Ishihara T; Ohshima T; Baba T; Shirai Y; Tadenuma H; Nakamura K; Saisho H
Pancreas; 2005 Jul; 31(1):74-8. PubMed ID: 15968251
[TBL] [Abstract][Full Text] [Related]
8. The assessment of serum concentration of adiponectin, leptin and serum carbohydrate antigen-19.9 in patients with pancreatic cancer and chronic pancreatitis.
Dranka-Bojarowska D; Lekstan A; Olakowski M; Jablonska B; Lewinski A; Musialski P; Sobczyk W; Kapalka A; Lampe P
J Physiol Pharmacol; 2015 Oct; 66(5):653-63. PubMed ID: 26579571
[TBL] [Abstract][Full Text] [Related]
9. Th1 and Th2 profiles in patients with pancreatic cancer compared with chronic pancreatitis.
Seicean A; Popa D; Mocan T; Cristea V; Berindan-Neagoe I
Pancreas; 2009 Jul; 38(5):594-5. PubMed ID: 19550277
[No Abstract] [Full Text] [Related]
10. Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by (1)H nuclear magnetic resonance-based metabonomic profiles.
Zhang L; Jin H; Guo X; Yang Z; Zhao L; Tang S; Mo P; Wu K; Nie Y; Pan Y; Fan D
Clin Biochem; 2012 Sep; 45(13-14):1064-9. PubMed ID: 22613268
[TBL] [Abstract][Full Text] [Related]
11. [Differential diagnosis between pancreatic carcinoma and chronic pancreatitis].
Maede Y; Shimizu K; Takayama Y; Shiratori K
Nihon Rinsho; 2006 Jan; 64 Suppl 1():170-4. PubMed ID: 16457243
[No Abstract] [Full Text] [Related]
12. Plasma concentrations of angiogenesis-related molecules in patients with pancreatic cancer.
Sakamoto H; Kimura H; Sekijima M; Matsumoto K; Arao T; Chikugo T; Yamada Y; Kitano M; Ito A; Takeyama Y; Kudo M; Nishio K
Jpn J Clin Oncol; 2012 Feb; 42(2):105-12. PubMed ID: 22167663
[TBL] [Abstract][Full Text] [Related]
13. The sensitivity of combined IgG4 and IgG in autoimmune pancreatitis.
Xin L; Liao Z; Hu LH; Li ZS
Am J Gastroenterol; 2010 Aug; 105(8):1902. PubMed ID: 20686470
[No Abstract] [Full Text] [Related]
14. Markers of angiogenesis and epidermal growth factor receptor signalling in patients with pancreatic and gastroesophageal junction cancer.
Rohrberg KS; Skov BG; Lassen U; Christensen IJ; Høyer-Hansen G; Buysschaert I; Pappot H
Cancer Biomark; 2010; 7(3):141-51. PubMed ID: 21263190
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of the measurements of serum matrix metalloproteinase-9 and its inhibitor (tissue inhibitor of metalloproteinase-1) in patients with pancreatic cancer: metalloproteinase-9 as an independent prognostic factor.
Mroczko B; Lukaszewicz-Zajac M; Wereszczynska-Siemiatkowska U; Groblewska M; Gryko M; Kedra B; Jurkowska G; Szmitkowski M
Pancreas; 2009 Aug; 38(6):613-8. PubMed ID: 19629003
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor (VEGF) genotype and serum concentration in patients with pancreatic adenocarcinoma and chronic pancreatitis.
Talar-Wojnarowska R; Gasiorowska A; Olakowski M; Lekstan A; Lampe P; Smolarz B; Romanowicz-Makowska H; Kulig A; Malecka-Panas E
J Physiol Pharmacol; 2010 Dec; 61(6):711-6. PubMed ID: 21224502
[TBL] [Abstract][Full Text] [Related]
17. Editorial comment. Pancreatic diseases.
Owyang C
Curr Opin Gastroenterol; 2007 Sep; 23(5):491-3. PubMed ID: 17762553
[No Abstract] [Full Text] [Related]
18. Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9.
Koopmann J; Rosenzweig CN; Zhang Z; Canto MI; Brown DA; Hunter M; Yeo C; Chan DW; Breit SN; Goggins M
Clin Cancer Res; 2006 Jan; 12(2):442-6. PubMed ID: 16428484
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis.
Rychlíková J; Vecka M; Jáchymová M; Macášek J; Hrabák P; Zeman M; Vávrová L; Řoupal J; Krechler T; Ák A
Cancer Biomark; 2016 Jun; 17(1):55-65. PubMed ID: 27314293
[TBL] [Abstract][Full Text] [Related]
20. Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts.
Bockhorn M; Tsuzuki Y; Xu L; Frilling A; Broelsch CE; Fukumura D
Clin Cancer Res; 2003 Sep; 9(11):4221-6. PubMed ID: 14519649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
